Unnamed: 0,title,date,stock,sentiment
680672.0,"IRADIMED Reports Roger Susi To Resume His Duties As Pres, CEO",2020-05-29 07:07:00-04:00,IRMD,neutral
680673.0,IRADIMED Announces Issuance Of US Patent,2020-05-11 07:20:00-04:00,IRMD,neutral
680674.0,Recap: iRadimed Q1 Earnings,2020-04-30 09:39:00-04:00,IRMD,neutral
680675.0,"The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1",2020-04-30 07:19:00-04:00,IRMD,positive
680676.0,"iRadimed Q1 Adj. EPS $0.180 Beats $0.150 Estimate, Sales $8.678M Miss $9.660M Estimate",2020-04-30 07:03:00-04:00,IRMD,negative
680677.0,"The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight",2020-04-26 16:37:00-04:00,IRMD,negative
680678.0,"IRADIMED CORPORATION Sees Prelim. Q1 Sales $8.6M-$8.7M, Withdraws 2020 Financial Guidance",2020-04-07 07:11:00-04:00,IRMD,neutral
680679.0,Stocks That Hit 52-Week Lows On Monday,2020-03-23 10:34:00-04:00,IRMD,negative
680680.0,"The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index",2020-03-10 09:19:00-04:00,IRMD,negative
680681.0,"IRadimed Sees Q1 Adj. EPS $0.19-$0.21 vs $0.20 Est., Sales $10.5M-$10.7M vs $10.84M Est.; Sees FY20 Adj. EPS $0.84-$0.92 vs $0.92 Est., Sales $46.3M-$47.1M vs $46.96M Est.",2020-02-06 07:49:00-05:00,IRMD,neutral
680682.0,"iRadimed Q4 Adj. EPS $0.30 Beats $0.2 Estimate, Sales $10.891M Miss $10.92M Estimate",2020-02-06 07:48:00-05:00,IRMD,negative
680683.0,iRadimed Sees Q4 Adj. EPS $0.19-$0.21 vs $0.23 Estimate; FY19 Adj. EPS $0.75-$0.77 vs $0.72 Est.,2019-10-30 07:25:00-04:00,IRMD,neutral
680684.0,"iRadimed Q3 Adj. EPS $0.23 Beats $0.15 Estimate, Sales $9.963M Beat $9.78M Estimate",2019-10-30 07:24:00-04:00,IRMD,neutral
680685.0,"The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings",2019-10-30 07:01:00-04:00,IRMD,negative
680686.0,IRADIMED Resolves FDA Warning Letter Related To Its Infusion Pump System,2019-10-08 07:05:00-04:00,IRMD,negative
680687.0,56 Biggest Movers From Friday,2019-09-16 05:29:00-04:00,IRMD,neutral
680688.0,80 Biggest Movers From Yesterday,2019-07-31 05:28:00-04:00,IRMD,neutral
680689.0,Mid-Afternoon Market Update: Crude Oil Up Over 2%; CNX Resources Shares Climb After Q2 Results,2019-07-30 14:34:00-04:00,IRMD,negative
680690.0,58 Stocks Moving In Tuesday's Mid-Day Session,2019-07-30 12:39:00-04:00,IRMD,neutral
680691.0,Mid-Day Market Update: Iradimed Surges Following Strong Q2 Results; McDermott Shares Plunge,2019-07-30 12:08:00-04:00,IRMD,positive
680692.0,iRadimed Raises FY19 Adj. EPS Guidance From $0.69-$0.73 To $0.70-$0.74 vs $0.70 Est.,2019-07-30 07:08:00-04:00,IRMD,neutral
680693.0,"iRadimed Q2 EPS $0.2 Beats $0.15 Estimate, Sales $9.23M Beat $8.91M Estimate",2019-07-30 07:07:00-04:00,IRMD,neutral
680694.0,"The Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On Earnings",2019-07-30 07:00:00-04:00,IRMD,positive
680695.0,"IRADIMED Names Leslie McDonnell Pres, CEO",2019-07-29 16:00:00-04:00,IRMD,neutral
680696.0,"The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate",2019-07-27 14:32:00-04:00,IRMD,negative
680697.0,"The Daily Biotech Pulse: Hookipa Leaps, Illumina Dims On Q2 Warning, Novartis-Amgen Halt Alzheimer's Study",2019-07-12 07:24:00-04:00,IRMD,negative
680698.0,68 Biggest Movers From Yesterday,2019-05-01 06:01:00-04:00,IRMD,neutral
680699.0,"IRadimed Sees Q2 Adj. EPS $0.14-$0.15 vs $0.17 Est., Sales $8.8M-$9.0M vs $9.39M Est.; Sees FY19 Adj. EPS $0.69-$0.73 vs $0.72 Est., Sales $38.5M-$39.5M vs $38.88M Est.",2019-04-30 07:14:00-04:00,IRMD,neutral
680700.0,"iRadimed Q1 EPS $0.13 Misses $0.15 Estimate, Sales $8.4M Miss $8.44M Estimate",2019-04-30 07:12:00-04:00,IRMD,negative
680701.0,IRADIMED CORPORATION Announces FDA 510(k) Clearance For Neonatal Pulse Oximetry And Capnography Monitoring Using Its MRI-Compatible Patient Vital Signs Monitor,2019-04-02 07:13:00-04:00,IRMD,positive
680702.0,"On March 26, 2019, Iradimed Entered into Amendment with Fukoku Co., Ltd. Extending Term of Supply Agreement through February 25, 2024",2019-04-01 06:25:00-04:00,IRMD,positive
680703.0,"IRadimed Corporation Sees Q1 Adj. EPS $0.12-$0.13 vs $0.15 Est., Sales $8.3M-$8.5M vs $9.1M Est.; Sees FY19 Adj. EPS $0.69-$0.73 vs $0.73 Est., Sales $38.5M-$39.5M vs $40.2M Est.",2019-02-06 07:05:00-05:00,IRMD,neutral
680704.0,"iRadimed Q4 Adj. EPS $0.16 Beats $0.13 Estimate, Sales $8.3M Beat $8.15M Estimate",2019-02-06 07:04:00-05:00,IRMD,neutral
680705.0,IRADIMED Expects Minor Impact To 2019 Sales After Temporarily Suspending Shipments Of MRI Compatible Patient Vital Signs Monitoring Systems In European Markets,2019-01-22 07:13:00-05:00,IRMD,positive
680706.0,IRADIMED Reports 510(k) Clearance For Its Invasive Blood Pressure Module for Us With MRI-Compatible Patient Vital Signs Monitor,2018-12-19 07:08:00-05:00,IRMD,neutral
680707.0,50 Biggest Movers From Yesterday,2018-12-18 06:11:00-05:00,IRMD,neutral
680708.0,IRadimed Corporation Sees Q4 Adj. EPS $0.12-$0.13 vs $0.14 Est.,2018-10-30 07:08:00-04:00,IRMD,neutral
680709.0,"IRadimed Corporation Raises FY18 Adj. EPS Guidance From $0.45-$0.47 To $0.50-$0.51 vs $0.47 Est., Raises FY18 Sales Guidance From $29.5M-$30.2M To $30.0M-$30.2M vs $30.23M Est.",2018-10-30 07:07:00-04:00,IRMD,neutral
680710.0,"iRadimed Q3 Adj. EPS $0.14 Beats $0.10 Estimate, Sales $7.6M Beat $7.51M Estimate",2018-10-30 07:05:00-04:00,IRMD,neutral
680711.0,"Stocks Which Set New 52-Week High Yesterday, October 1st",2018-10-02 09:20:00-04:00,IRMD,neutral
680712.0,"Stocks Which Set New 52-Week High Yesterday, September 26th",2018-09-27 09:12:00-04:00,IRMD,neutral
680713.0,"Stocks Which Set New 52-Week High Yesterday, September 25th",2018-09-26 11:53:00-04:00,IRMD,neutral
680714.0,"Stocks Which Set New 52-Week High Friday, September 21",2018-09-24 09:43:00-04:00,IRMD,neutral
680715.0,"Stocks Which Set New 52-Week High Yesterday, September 20th",2018-09-21 08:16:00-04:00,IRMD,neutral
680716.0,"Stocks Which Set New 52-Week High Yesterday, September 17th",2018-09-18 09:25:00-04:00,IRMD,neutral
680717.0,"Stocks Which Set New 52-Week High Yesterday, September 12",2018-09-13 09:44:00-04:00,IRMD,neutral
680718.0,IRadimed Corp Announces Clearance For IRADIMED 3880 MRI Compatible Patient Vital Signs Monitor In Japan,2018-09-11 07:03:00-04:00,IRMD,positive
680719.0,"The Daily Biotech Pulse: Cesca, Acer Therapeutics Rally On Earnings, Aridis Makes Its Nasdaq Debut",2018-08-14 08:23:00-04:00,IRMD,neutral
680720.0,"Stocks Which Set New 52-Week High Yesterday, August 8th",2018-08-09 11:03:00-04:00,IRMD,neutral
680721.0,"Stocks Which Set New 52-Week High Yesterday, August 6th",2018-08-07 11:27:00-04:00,IRMD,neutral
680722.0,"The Daily Biotech Pulse: FDA Snub For Gemphire, Ligand Earnings, Insmed's Antibiotic Faces FDA Panel",2018-08-07 08:23:00-04:00,IRMD,negative
680723.0,"Stocks Which Set New 52-Week Highs Friday, August 3rd",2018-08-06 13:02:00-04:00,IRMD,neutral
680724.0,"Stocks Which Set New 52-Week High Yesterday, August 1st",2018-08-02 10:56:00-04:00,IRMD,neutral
680725.0,"The Daily Biotech Pulse: Denali's Parkinson's Candidate Clears Early-Stage Trials, Dexcom's Strong Quarter",2018-08-02 08:54:00-04:00,IRMD,positive
680726.0,Benzinga Pro's 5 Stocks To Watch Today,2018-07-31 09:01:00-04:00,IRMD,neutral
680727.0,"iRadimed Raises FY18 Guidance: Adj. EPS From $0.40-$0.43 To $0.45-$0.47 vs $0.42 Estimate, Sales From $29.3M-$30M To $29.5M-$30.1M vs $30.06M Est.",2018-07-31 07:22:00-04:00,IRMD,neutral
680728.0,"iRadimed Sees Q3 Adj. EPS $0.09-$0.10 vs $0.09 Estimate, Sales $7.4M-$7.5M vs $7.34M Est.",2018-07-31 07:21:00-04:00,IRMD,neutral
680729.0,"iRadimed Q2 EPS $0.14 Beats $0.10 Estimate, Sales $7.377M Beat $7.23M Estimate",2018-07-31 07:20:00-04:00,IRMD,neutral
680730.0,"Benzinga's Daily Biotech Pulse: Pfizer To Defer Price Hikes, Idera-BioCryst Merger Falls Through, ArQule To Offer Shares",2018-07-11 08:15:00-04:00,IRMD,neutral
680731.0,36 Stocks Moving In Monday's Mid-Day Session,2018-04-30 13:16:00-04:00,IRMD,neutral
680732.0,"IRADIMED Sees Q2 EPS $0.10-$0.11 vs $0.09 Est., Sales $7.2-$7.3M vs $7.1M Est.; Raises FY18 EPS From $0.33-$0.38 To $0.40-$0.43, Sales $29.3M-$30M vs $29.9M Est.",2018-04-30 07:07:00-04:00,IRMD,neutral
680733.0,"IRADIMED Q1 EPS $0.10 Beats $0.06 Est., Sales $7.1M Beats $6.85M Est.",2018-04-30 07:06:00-04:00,IRMD,neutral
680734.0,"IRADIMED CORPORATION Sees Q1 Sales $6.8-$6.9M vs $6.8M Est., EPS $0.06-$0.07 vs $0.07 Est.",2018-02-06 07:01:00-05:00,IRMD,neutral
680735.0,"IRADIMED CORPORATION Reports Q4 Adj. EPS $0.10 vs $0.06 Est., Sales $6.7M vs $6.6M Est.",2018-02-06 07:01:00-05:00,IRMD,neutral
680736.0,iRadimed Sees FY2018 EPS $0.33-0.38 vs $0.28 Est,2018-01-22 07:02:00-05:00,IRMD,neutral
680737.0,iRadimed Sees Q1 EPS $0.06-0.07 vs $0.06 Est,2018-01-22 07:01:00-05:00,IRMD,neutral
680738.0,"Roth Capital Reinstates Buy on iRadimed, Announces $16.00",2017-10-31 09:00:00-04:00,IRMD,neutral
680739.0,IRADIMED Raises FY 2017 Guidance From $0.14-$0.18 to $0.17-$0.18 vs $0.13 Est.,2017-10-30 07:03:00-04:00,IRMD,neutral
680740.0,"IRADIMED Q3 Adj. EPS $0.07 vs $0.03 Est., Sales $5.7M vs $5.6M Est.",2017-10-30 07:02:00-04:00,IRMD,neutral
680741.0,32 Stocks Moving In Friday's Pre-Market Session,2017-10-27 08:04:00-04:00,IRMD,neutral
680742.0,40 Biggest Movers From Yesterday,2017-10-27 04:57:00-04:00,IRMD,neutral
680743.0,35 Stocks Moving In Thursday's Mid-Day Session,2017-10-26 12:44:00-04:00,IRMD,neutral
680744.0,Roth Capital Upgrades iRadimed to Buy,2017-07-31 08:31:00-04:00,IRMD,neutral
680745.0,18 Biggest Mid-Day Gainers For Friday,2017-07-28 12:39:00-04:00,IRMD,neutral
680746.0,"IRADIMED Sees Q3 Adj. EPS $0.02-$0.03 vs $0.03 Est., Sales $5.5M-$5.6M vs $5.75M Est.",2017-07-28 07:15:00-04:00,IRMD,neutral
680747.0,"IRADIMED Reports Q2 Adj. EPS $0.06 vs $0.01 Est., Sales $5.5M vs $5.4M Est.",2017-07-28 07:08:00-04:00,IRMD,neutral
680748.0,IRADIMED Names John McCreery COO,2017-03-30 09:43:00-04:00,IRMD,neutral
680749.0,"IRADIMED Corp. Reports Q4 EPS $0.11 vs. Est. $0.04, Rev. $6M vs. Est. $6.09M",2017-02-06 07:01:00-05:00,IRMD,neutral
680750.0,15 Biggest Mid-Day Losers For Wednesday,2017-01-18 12:52:00-05:00,IRMD,negative
680751.0,"IRADIMED Corp. Sees Q1 EPS $0.00-$0.01 vs. Est. $0.06, Rev. $5.2-$5.3M vs. Est. $6.5M; FY16 Rev. $23.9-$24.3M vs. Est. $24M, EPS $0.14-$0.18 vs. Est. $0.28",2017-01-18 07:04:00-05:00,IRMD,neutral
680752.0,IRADIMED Gets 501(k) Clearance From FDA for MRI Compatible IV Infusion Pump,2016-12-19 07:06:00-05:00,IRMD,neutral
680753.0,"IRADIMED CORP: Susi Roger E. (Director, CEO, President, Chairman, 10%+) Buys 5,000 @ Avg Price: $11.24 (Form4",2016-12-01 07:26:00-05:00,IRMD,neutral
680754.0,"IRADIMED Reports Q3 Adj. EPS $0.14 vs $0.11 Est., Sales $7.7M",2016-10-28 07:11:00-04:00,IRMD,neutral
680755.0,Benzinga's Top Downgrades,2016-10-05 09:31:00-04:00,IRMD,positive
680756.0,Roth Capital Downgrades iRadimed to Neutral,2016-10-05 04:47:00-04:00,IRMD,neutral
680757.0,Mid-Afternoon Market Update: Dow Drops More Than 100 Points; Summit Therapeutics Shares Spike Higher,2016-10-04 14:33:00-04:00,IRMD,positive
680758.0,12 Biggest Mid-Day Losers For Tuesday,2016-10-04 12:50:00-04:00,IRMD,negative
680759.0,Mid-Day Market Update: Dow Turns Negative; SeaDrill Shares Climb On News Of Potential Refinancing,2016-10-04 12:13:00-04:00,IRMD,negative
680760.0,Iradimed Sinks 30% On Sharply Cut Guidance,2016-10-04 11:29:00-04:00,IRMD,negative
680761.0,Stocks Hitting 52-Week Lows,2016-10-04 10:41:00-04:00,IRMD,negative
680762.0,Mid-Morning Market Update: Markets Open Higher; Darden Profit Beats Estimates,2016-10-04 10:02:00-04:00,IRMD,positive
680763.0,15 Stocks Moving In Tuesday's Pre-Market Session,2016-10-04 08:23:00-04:00,IRMD,neutral
680764.0,iRadimed Lowers FY2016 EPS Guidance from $0.91-0.93 to $0.60-0.63; Lowers FY2016 Sales Guidance from $39.0M-40.0M to $32.90M-33.20M,2016-10-04 06:57:00-04:00,IRMD,negative
680765.0,iRadimed Lowers Q3 EPS Guidance from $0.23-0.24 to $0.11-0.12; Lowers Q3 Sales Guidance from $9.90M-10.0M to $7.50M-7.60M,2016-10-04 06:57:00-04:00,IRMD,negative
680766.0,"IRADIMED Reports Q2 Adj. EPS $0.24 vs $0.21 Est., Sales $9.9M vs $9.6M Est.",2016-07-29 07:08:00-04:00,IRMD,neutral
680767.0,"IRADIMED Sees Q3 Rev. $9.9-$10M vs. Est. $9.9M, EPS $0.23-$0.24 vs. Est. $0.22",2016-07-29 07:04:00-04:00,IRMD,neutral
680768.0,"IRADIMED CORP. Reports Q2 EPS $0.24 vs. Est. $0.21, Rev. $9.9M vs. Est. $9.6M",2016-07-29 07:03:00-04:00,IRMD,neutral
680769.0,Iradimed Corp Names Roger Susi Chair,2016-06-14 16:04:00-04:00,IRMD,neutral
680770.0,"IRADIMED Sees FY16 Adj. EPS $0.88-$0.90 vs $0.83 Est., Sales $39M-$40M vs $39.2M Est.",2016-04-29 07:09:00-04:00,IRMD,neutral
680771.0,"IRADIMED Sees Q2 Sales ~$9.6M-$9.7M vs $9.32M Est., Adj. EPS $0.21-$0.22 vs $0.20 Est.",2016-04-29 07:09:00-04:00,IRMD,neutral
680772.0,"IRADIMED Reports Q1 Adj. EPS $0.21 vs $0.18 Est., Sales $9M vs $9.05M Est.",2016-04-29 07:08:00-04:00,IRMD,neutral
680773.0,Mid-Afternoon Market Update: Dow Drops Over 50 Points; Edwards Lifesciences Shares Rise Following Positive Trial,2016-04-04 14:41:00-04:00,IRMD,positive
680774.0,Mid-Day Market Update: Ruckus Wireless Surges On Acquisition News; Smith & Wesson Shares Slide,2016-04-04 12:18:00-04:00,IRMD,positive
680775.0,Mid-Morning Market Update: Markets Mostly Flat; Alaska Air To Acquire Virgin America For $57/Share,2016-04-04 10:12:00-04:00,IRMD,neutral
680776.0,"Roth Capital Maintains Buy on iRadimed, Lowers PT to $25.00",2016-04-04 08:17:00-04:00,IRMD,negative
680777.0,"Roth Capital Maintains Buy on iRadimed, Lowers PT to $25.00 'to account for the increased regulatory uncertainty'",2016-04-04 05:59:00-04:00,IRMD,negative
680778.0,Iradimed Shares Selloff to $15 Following Announcement of FDA Denial,2016-04-01 16:04:00-04:00,IRMD,positive
680779.0,"Iradimed  Says Notified By FDA On March 23, 2016 That Co'S 510(K) Application Was Denied With A Finding Of Non-Substantial Equivalence",2016-04-01 16:03:00-04:00,IRMD,negative
680780.0,"IRADIMED Sees Q1 Adj. EPS $0.17-$0.18 vs $0.18 Est., Sales $9M-$9.1M vs $9.1M Est.; Sees FY16 Adj. EPS $0.83-$0.85 vs $0.83 Est., Sales $39M-$40M vs $39M Est.",2016-02-05 07:01:00-05:00,IRMD,neutral
680781.0,"IRADIMED Reports Q4 Adj. EPS $0.22 vs $0.19 Est., Sales $8.8M, Inline",2016-02-05 07:00:00-05:00,IRMD,neutral
680782.0,IRADIMED Corp. Reports $10M Buyback,2016-01-28 10:59:00-05:00,IRMD,neutral
680783.0,IRADIMED CORP. Prices 1.043M Secondary Offering At $24.25/Share,2015-12-18 08:32:00-05:00,IRMD,neutral
680784.0,Iradimed Corp Proposes Offering Of Common Shares,2015-12-17 16:02:00-05:00,IRMD,positive
680785.0,Iradimed Says Will Continue to Work with FDA During Review of 510(K),2015-12-10 10:48:00-05:00,IRMD,neutral
680786.0,Iradimed Files $40M Shelf Offering For Common Shares,2015-11-03 17:10:00-05:00,IRMD,positive
680787.0,"IRADIMED Raises FY15 Sales Outlook from $30.2M-$30.4M to $31.3M-$31.4M vs $30.2M Est., Adj. EPS from $0.63-$0.65 to $0.68-$0.69 vs $0.63 Est.",2015-10-30 07:34:00-04:00,IRMD,neutral
680788.0,"IRADIMED Sees Q4 Sales $8.5M-$8.6M vs $7.9M Est., Adj. EPS $0.19-$0.20 vs $0.17 Est.",2015-10-30 07:33:00-04:00,IRMD,neutral
680789.0,"IRADIMED Reports Q3 Adj. EPS $0.19 vs $0.16 Est., Sales $8.2M vs $7.7M Est.",2015-10-30 07:33:00-04:00,IRMD,neutral
680790.0,"IRADIMED Reports Q2 Adj. EPS $0.16 vs $0.12 Est., Sales $7.6M vs $7.1M Est.; Raises FY15 Sales, Adj. EPS Outlook, Sees  Q3 Sales $7.7M-$7.8M vs $7.4M Est., Adj. EPS $0.16-$0.17 vs $0.13 Est.",2015-07-30 07:41:00-04:00,IRMD,neutral
680791.0,"iRadimed Analyst Believes Move Lower in Stock Seems Like Incorrect Market Response, Believes News is Favorable",2015-05-27 15:40:00-04:00,IRMD,positive
680792.0,District Courts Get Motion To Dismiss All Claims,2015-05-27 15:33:00-04:00,IRMD,neutral
680793.0,"IRadimed Corp Reports Inline Q1 EPS $0.12, Sales $6.99M Vs Est $6.90M",2015-04-30 07:11:00-04:00,IRMD,neutral
680794.0,UPDATE: iRadimed Sees FY2015 EPS $0.50-0.52; Sees Sales $28.0M-29.0M,2015-01-12 07:09:00-05:00,IRMD,neutral
680795.0,UPDATE: iRadimed Raises Q4 Sales Guidance from $3.0M to $3.50M,2015-01-12 07:09:00-05:00,IRMD,neutral
680796.0,iRadimed Sees Q1 EPS $0.11-0.13,2015-01-12 07:05:00-05:00,IRMD,neutral
680797.0,"IRADIMED Announces Resumption of Domestic Distribution of Infusion Pumps, Does Not Expect DERS Option to be Available til 510(k) Cleared",2014-12-22 07:24:00-05:00,IRMD,positive
680798.0,IRADIMED CORPORATION Files 510(k) Submission For Premarket Notification With FDA,2014-11-25 11:12:00-05:00,IRMD,neutral
680799.0,"Midday Losers From Wednesday, September 3",2014-09-03 14:50:00-04:00,IRMD,negative
680800.0,Stocks Hitting 52-Week Lows,2014-09-03 10:21:00-04:00,IRMD,negative
680801.0,Morning Market Losers ,2014-09-03 09:50:00-04:00,IRMD,negative
680802.0,US Stock Futures Climb Ahead Of Fed's Beige Book,2014-09-03 07:13:00-04:00,IRMD,neutral
680803.0,IRADIMED Announces Receipt of FDA Warning Letter Regarding Inspection of Facility,2014-09-03 05:27:00-04:00,IRMD,negative
680804.0,iRadimed Corp. Sees FY2014 Sales $18.0M-18.20M,2014-08-12 07:23:00-04:00,IRMD,neutral
680805.0,iRadimed Corp. Sees Q4 EPS $0.07-0.08,2014-08-12 07:23:00-04:00,IRMD,neutral
680806.0,iRadimed Corp. Sees Q3 EPS $0.07,2014-08-12 07:23:00-04:00,IRMD,neutral
680807.0,iRadimed Corp. Reports Q2 EPS of $0.13; Revenue of $4.70M,2014-08-12 07:22:00-04:00,IRMD,neutral
680808.0,"Roth Capital Initiates Coverage on iRadimed Corp. at Buy, Announces $14.00 PT",2014-08-11 09:45:00-04:00,IRMD,neutral
680809.0,"Iradimed Shares Resume Trade, Now at $9.15",2014-07-16 10:09:00-04:00,IRMD,positive
680810.0,"Iradimed Shares Halted on Circuit Breaker, Stock Now at $9.12 After Hitting a High at $11.27",2014-07-16 10:05:00-04:00,IRMD,positive
680811.0,"UPDATE: Shares of Iradimed Touched as High as $11.27, Now Around $10.09",2014-07-16 10:02:00-04:00,IRMD,positive
680812.0,Shares of Iradimed Open at $10 After Pricing IPO at $6.25/Share,2014-07-16 10:01:00-04:00,IRMD,positive
680813.0,iRadimed Prices IPO at $6.25/Share,2014-07-16 08:33:00-04:00,IRMD,neutral
680814.0,Iradimed Expects 1.75M Share IPO to Price $5.00-$6.00/Share,2014-07-09 06:17:00-04:00,IRMD,positive
680815.0,"iRadimed Files $11.5M IPO, Planning to List on NASDAQ Under 'IRMD'",2014-06-18 16:34:00-04:00,IRMD,neutral
